Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

Todd Neale

January 29, 2026

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

News Conference News AHA 2016

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Michael O'Riordan

November 22, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

Advertisement

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Recurrent Events Common Among Young Patients With CAD

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content